Erratum to Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Erratum to Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate ; volume:9 ; number:4 ; day:4 ; month:6 ; year:2008 ; pages:257 ; date:8.2008
The journal of headache and pain ; 9, Heft 4 (4.6.2008), 257, 8.2008
- Creator
-
Togha, Mansoureh
Rahmat Jirde, Masoud
Nilavari, Kiafar
Ashrafian, Hosein
Razeghi, Soodeh
Kohan, Leila
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10194-008-0044-8
- URN
-
urn:nbn:de:101:1-2021081509020336347963
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Togha, Mansoureh
- Rahmat Jirde, Masoud
- Nilavari, Kiafar
- Ashrafian, Hosein
- Razeghi, Soodeh
- Kohan, Leila
- SpringerLink (Online service)
Other Objects (12)
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
Valproate
The sense of stopping migraine prophylaxis
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
Riboflavin prophylaxis in pediatric and adolescent migraine
Combined Interventional Treatment of Refractory Chronic Migraine
Refractory migraine in a headache clinic population
Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
Identifying and managing refractory migraine: barriers and opportunities?
Thrombin Generation by Valproate
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Combining treatments for migraine prophylaxis: the state-of-the-art
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
Valproate
The sense of stopping migraine prophylaxis
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
Riboflavin prophylaxis in pediatric and adolescent migraine
Combined Interventional Treatment of Refractory Chronic Migraine
Refractory migraine in a headache clinic population
Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
Identifying and managing refractory migraine: barriers and opportunities?
Thrombin Generation by Valproate
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Combining treatments for migraine prophylaxis: the state-of-the-art
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
Valproate
The sense of stopping migraine prophylaxis
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
Riboflavin prophylaxis in pediatric and adolescent migraine
Combined Interventional Treatment of Refractory Chronic Migraine
Refractory migraine in a headache clinic population
Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
Identifying and managing refractory migraine: barriers and opportunities?
Thrombin Generation by Valproate
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine